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Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is one of the dietary flavonoids, distributed inmedicinal plants, vegetables, and fruits.
Quercetin has the ability to bind with several metal ions to increase its biological activities. In the last two decades, quercetin has
attracted considerable attention due to the biological and pharmaceutical activities such as antioxidant, antibacterial, and an-
ticancer. In the present study, quercetin and ethanolamine were used for the synthesis Schiff base complex, which was char-
acterized by IR, 1H NMR, and 13C NMR spectroscopy. +e Schiff base has been employed as a ligand for the synthesis of novel
nanoscale Cu (II) complex. +e product was characterized by FT-IR spectroscopy, FESEM, and XRD. Significantly, the product
showed remarkable catalytic activity towards the oxidation of primary and secondary alcohols. +e antibacterial activity of the
final product was assessed against Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative) bacteria using an
inhibition zone test. +e synthesized nanoscale Cu (II) complex exhibited a strong antibacterial activity against both Gram-
positive and Gram-negative bacteria.
1. Introduction
Flavonoids are the largest group of phenolic compounds that
have different biological and medicinal properties, such as
antioxidant, [1] antibacterial, [2] antidiabetic, [3] anticancer,
[4–6] antiatherosclerosis [7], and neuroprotective effects [8].
Flavonoids consist of two benzene rings joined by a 3-carbon
bridge (C6-C3-C6) (Figure 1) [9]. Flavonoids can be divided
into several different classes, such as flavones (e.g., flavone,
luteolin, and apigenin), flavonols (e.g., quercetin, kaemp-
ferol, fisetin, and myricetin), and flavanones (e.g., flavanone,
naringenin, and hesperetin).+ese classes are different in the
oxidation and pattern of substitution of the C ring, while in
each class, they differ in the pattern of substitution of the A
and B rings [10].
Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is one of the
flavonoids which attracted more attention in recent years
(Figure 2) [11]. +is phenolic compound is a dietary fla-
vonoid which existed in onions, apples, broccoli, berries,
tomato, and lettuce, linked to the cell wall matrix [11–15].
Quercetin is a bioflavonoid that can protect tissues from
injury induced by some drug toxicities [16].
Quercetin has poor solubility, so it seems to be difficult
to absorb into the body [17, 18]. Several studies have been
performed to modify the quercetin structure to increase its
water solubility and bioavailability and thus enhance its
pharmacological effects [19–23]. Studies have shown that
coordination of quercetin with metal ions can increase the
antioxidant activity and ultraoxygen anion elimination than
quercetin itself [24–26]. +e strong ability of quercetin to
chelate with different metal ions such as Tb(III) [27], Mg(II)
[28], Cu(II) [29], Fe(II) [3], Cr(III) [30], Co(II) [31], Sn(II)
[32], Vo(IV) [33], Zn(II) [34], Mn(II) [35], Pb(II) [36], and
Ni(II) [37] can increase the solubility and bioavailability of
quercetin and promote new pharmacological activity [38].
Quercetin has two aromatic rings and an oxygenated
heterocyclic ring containing a carbonyl group at 4-position
and hydroxyl group at 3-carbon chain [39]. Functional
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hydroxyl groups in the flavonoids cause antioxidant activity
by scavenging free radicals and chelating metal ions. +e
chelation of metals can prevent radical generation which
damages target biomolecules. Naidu and Kinthada [40]
showed that quercetin and quercetin-3-glycoside can react
with thiosemicarbazide in methanol and produce thio-
semicarbazone derivatives that can form stable complexes in
reaction with some transition metals.
Interaction of quercetin with metal ions can change its
antioxidant and biological activities due to the ability of this
complex as a free radical scavenger [41, 42]. Studies show
that the 3′,4′-ortho-dihydroxy substitution in the B ring is
critical for copper ion chelation with quercetin to increase
the antioxidant activity [43].
Copper is a bio-essential element for all organisms. It is
used as a metal cofactor by some enzymes, including cy-
tochrome c oxidase (Cox) and superoxide dismutase (SOD).
In the body, copper is present in Cu+ and Cu2+ forms. It acts
as an intermediary for electron transfer in redox reactions.
Copper is a critical element for neuronal function and
oxygen transport and a cofactor for many proteins [44–46]
and acts as a cofactor in blood for angiogenesis [41].
Copper complexes are getting more attention due to
their multiple bioactivities in living organism. Copper (II)
complexes play significant role in enhancing the pharma-
cological profile of the antimicrobial activities of some
bioactive compounds [42].
To date, the complexity of nanostructures has become
interesting for fundamental and practical studies. Rational
design of complex nanostructures can make new desired
materials with special properties [47].
In this study, we first focused on the synthesis of Schiff
base from the reaction between quercetin and ethanol amine
and subsequently synthesized novel nanoscale Cu (II)
complex as an excellent catalyst for alcohol oxidation. We
investigated the potential catalytic activity of the synthesized
catalyst in primary and secondary alcohol oxidation under
solvent-free conditions. +ese results showed that the cat-
alyst performs highly efficiently and due to its heterogeneous
nature, it can be used several times in the chemical reactions.
+e experimental results also showed the synthesized
nanoparticles have high antibacterial activity.
2. Materials and Methods
Quercetin, ethanolamine, and all solvents and reagents were
purchased from Sigma-Aldrich. All chemicals were used
without any further purification. +e progress of the reac-
tions and the purity of the products were monitored by TLC
(thin layer chromatography). Fourier transform infrared
(FT-IR) spectra were recorded with a Nicolet System 800
beam splitter in the range 400–4000 cm−1. NMR spectra
were recorded on Bruker Avance 400 Ultrashield NMR
spectrometers using tetramethylsilane as an internal stan-
dard. +e powder X-ray diffraction pattern (XRD) of the
final product was obtained with an X’Pert Pro-MPD dif-
fractometer between 2θ � 2°–80°. Inductively coupled plasma
(ICP) atomic emission spectroscopy was carried out by using
OPTIMA 7300DV. FESEM analysis was carried out by
MIRA TESCAN instrument to determine the morphology of
the nanoparticles.
2.1. Schiff Base Synthesis. +e synthesis of Schiff base as a
ligand is shown (Scheme 1). Quercetin (0.302 g, 1mmol) was
dissolved in ethanol (7ml). Glacial acetic acid (57 µl) was
added to this solution. Ethanol amine (60.2 µl, 1mmol) was
added dropwise to the reaction flask after 30 minutes. +e
reaction mixture was refluxed at 60°C for 8 hours with
stirring. +e resulting dark red solution was concentrated
and cooled, giving an orange crystalline precipitate after
recrystallization from a hot solution of ethanol and dried in
vacuo. +e colour of the Schiff base was light orange.
2.2. Synthesis of Nanoscale Cu (II) Complex. +e nanoscale
Cu (II) complex was synthesized according to a one-pot
strategy. First, the ligand (0.173 g, 0.5mmol) was dissolved by
adding NaOH 10% (1ml) in deionized water (20ml) under
magnetic stirring for 10minutes at room temperature to obtain
an orange solution. +en, a solution of Cu(OAc)2 (0.091 g,
0.5mmol) in deionized water (10ml) was added dropwise to
the mixture under ultrasonic irradiation at room temperature
andwas sonicated for 30min.+e resulting brownmixture was
centrifuged and placed in a vacuum oven at 80°C for 6 hours,
yielding dark orange precipitation (Scheme 2).
2.3. Catalytic Procedure for Alcohol Oxidation. +e synthe-
sized copper (II) complex was tested as a catalyst in benzyl







































Figure 2: Quercetin structure.
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experiments were carried out to optimize temperature, solvent,
and mol% of catalyst. +e best result in the model reaction was
chosen. In order to the investigation of solvent nature, the
model experiment was carried out in different solvents and the
best result was taken in solvent-free conditions. It seems that
open catalytic sites in this condition are the reason of this
observation. In the second step, the model reaction was carried
out at different temperatures. +e reaction yield at room
temperature, 40°C and 50°C, was 98%, so the reaction was
carried out at room temperature.+en, the catalyst and oxidant
amount were investigated. +e best yield was obtained in the
presence of 1mol% catalyst and 1mmol of TBHP. For the
investigation of oxidant type, the reaction was performed with
H2O2, TBHP, and NaIO4. With the optimized reaction con-
ditions, the best experiment as a model was chosen. 1mol% of
catalyst, 0.10mL (1mmol) of benzyl alcohol, and 0.096mL
(1mmol) of tert-butyl hydroperoxide (TBHP) as an oxidant
were mixed and stirred in solvent-free condition at room
temperature for half an hour. After the determination of op-
timum condition, the ability of the catalyst for a series of al-
cohols was evaluated (Table 1).
+e catalytic activity of the synthesized nanoparticles
was compared with some other catalysis in the alcohol
oxidation reaction (Table 2).
2.4. Antibacterial Activity. +e synthesized complex was
tested for in vitro antibacterial activity using the agar well
diffusion method. Staphylococcus aureus (Gram-positive) and
Escherichia coli (Gram-negative) were used as a model for this
activity. +e fresh bacteria were incubated on nutrient agar
plates at 37°C for 24 hours. A nutrient agar for the plates was
provided by dissolving agar powder (15.0 gL−1), tryptone
(5.0 g L−1), yeast extract (2.5 g L−1), and glucose (1.0 g L−1) in
deionized water. +e pH of the mixture was adjusted to
7.0± 0.1. +e diameter of the zone of inhibition was measured.
Gentamicin was used as a control substance. +e anti-
bacterial efficacy of the complex was tested against Staph-
ylococcus aureus and Escherichia coli bacteria. +e biocidal
effect of the copper complex was investigated by the dif-
fusion method. A bacterial suspension with a concentration
of 5×105 cfu/mL (200mL) was spread on the agar plates.
After the agar plates were incubated at 37°C for 48 hours, the
synthesized complex (1mg) was disposed directly into the
holes (7mm diameter) which were punched over the agar
plates previously.
+e evaluation of the antibacterial activity of the com-
plex was carried out by the standard zone of inhibition test.
+e diameter of the zone of inhibition was measured in mm
by the ruler.
3. Results and Discussion
+e formation of a Schiff base between quercetin and eth-
anolamine was investigated by NMR spectroscopy. NMR
data showed the formation of Schiff base from quercetin and
ethanol amine.
+e binding properties and the coordination sites were
investigated by using IR spectroscopy. +e main peaks of
quercetin, quercetin Schiff base, and quercetin Schiff base
complex are shown in Table 3. Important information was
obtained by comparing the quercetin with the Schiff base
and the complex. It was observed that C�O stretching mode
of free quercetin occurred at 1707 cm−1, which was shifted to
1695 cm−1 in the Schiff base, and it was shifted to 1622 cm−1
by the formation of the complex. A sharp peak at 1612 cm−1
shows the formation of the imine band in Schiff base. +e
sharp stretching vibration at 625 cm−1 shows Cu-O chelation
indicating the copper (II) is chelated to quercetin Schiff base
ligand and formed the metal complex while this stretching
band was absent in the FT-IR spectrum of the ligand. +e
broad medium intensity band at the frequency range of
3200–3450 cm−1 may be assigned to the -OH group. In the
quercetin Schiff base copper complex, a broad -OH group
was observed as broad vibrations around 3300 cm−1
(Figure 3).
3.1. SchiffBaseComplex. 1H NMR spectra of quercetin Schiff
base was obtained by using DMSO as a solvent and the main



















Scheme 1: Synthesis of the Schiff base ligand.











Scheme 2: Synthesis of the novel complex.
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aReaction conditions: alcohols (1mmol), TBHP (1mmol), and synthesized complex (1mol%) at room temperature and the absence of any solvent. bIsolated yield.
Table 2: Comparison of catalytic activity in alcohol oxidation reaction with previously reported catalysts.
Entry Catalyst Catalyst amount Condition Time (h) Yield (%) Ref.
1 Cu-MOF-2 17mol% CH3CN/O2/75°C 16 99 [43]
2 UiO-66-Sal-CuCl2 4mol% CH3CN/O2/60°C 24 99 [47]
3 [Co3L(PTA)2.5(OAc)]b 2mol% CH3CN/TBHP/60°C 24 88 [48]
4 [{Cu(L1)- (DMF)}·DMF·H2O]n a 0.2mol% MW/TBHP/100°C 0.5 81.1 [48]
5 Cu3(BTC)2 5mol% CH3CN/O2/70°C 9 94 [49]
6 Au@Cu(II)-MOF 3mol% Toluene/air/110°C 15 98 [50]
7 Cu-MOF-74 2.5mol% CH3CN/O2/70°C 12 89 [51]
8 SPS–Cu (II)@Cu3(BTC)2 2mol% CH3CN/O2/75°C 8 99 [52]
9 Pd@Cu(II)- MOF 5mol% Xylene/air/130°C 25 95 [53]
10 MIL-53(Fe)-graphene 15mol% CCl4/visible light 9 80 [54]
11 Synthesized nanoscale Cu (II) complex 1mol% SF/TBHP/rt 0.5 98 +is work
aPTA, p-phthalic acid; bL1, 5-{(pyridin-4-ylmethyl)amino} isophthalic acid.
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(2H, m), 6.43 (1H, d), 7.00 (1H, dd), 7.52 (2H, dd), 9.58 (2H,
s), 10.05 (3H, s), and 10.71 (1H, s) (Figure S1). +e 13C NMR
spectral data of the ligand were recorded in DMSO solution.
In the 13C NMR spectrum, characteristic peaks indicate the
formation of Cu(II) complex. +e main data are reported as
follows: δ 56.48 (C attached to the OH group of ethanol-
amine), 65.78 (C attached to the nitrogen in ethanolamine),
94.02 (C8), 99.05 (C6), 102.89 (C between C4 and C5), 115.43
(C2′), 116.12 (C5′), 120.35 (C6′), 122.42 (C1′), 128.78 (C3),
145.65 (C3′), 146.93 (C4′), 148.33 (C2), 156.73 (C between C8
and O in C ring), 162.85 (C7), 164.28 (C5), and 166.09 (C4)
(Figure S2).
+e synthesized nanoscale copper (II) complex was
confirmed by the EDX spectrum and FESEM image mea-
surement (Figure 4), which confirmed the highest formation
percent of Cu (II) complex. FESEM image for nanoscale
copper (II) complex showed nanoparticles with an average
diameter of 17 nm.
XRD of synthesized nanoscale copper (II) complex gives
characteristic peaks at 2θ � 32.12°, 35.37°, 38.77°, 48.67°,
53.37°, 57.92°, 62.52°, 67.62°, and 69.12°, indicating the for-
mation of Cu(II) complex (Figure 5) [55].
As the ratio of metal ion and ligand is 1 :1 and the 3-
hydroxy group has a more acidic proton, the 3-OH and N
positions are the best site to be involved in the complexation
process [29, 56]. +e OH group from the alcohol is not
coordinated, possibly due to the distance between OH group
and the center of reaction. Similar study confirms this
structure [57] (Figure 6).
+e oxidation of alcohols mechanism may involve the
generation of tBuOO• and t-BuO• radicals by the metal
assisted, which behave as hydrogen atom abstractors from
the alcohols. +e ligand can assist proton transfer steps
involved in the fundamental steps of the alcohol oxidation
reaction. +e mechanism is summarized in Scheme 3.
After optimizing reaction conditions, the effect of a
catalyst in a series of primary and secondary alcohols in-
cluding aromatic ring and electron donating and withdrawing
groups was evaluated.+e results are summarized in the table.
In general, all substrates showed an excellent yield in alcohol
oxidation reactions. Electron donating and electron with-
drawing groups change the reaction yield slightly.
+e recyclability of the catalyst was tested in the alcohol
oxidation reaction. +e complex was recovered from the
reaction after three times for the next reaction run by
centrifugation, washing, and drying in the oven.+is catalyst
was reused three times without any significant change of
catalytic activity.
+e synthesized complex was tested for the in vitro
antibacterial activity against E. coli (Gram-negative) and
Staphylococcus aureus (Gram-positive) bacteria at concen-
tration of 100mM. +e complex was active against both of
these bacteria. +e results of the antibacterial activity are
reported as inhibition zone diameter (mm).
+e antibacterial activity of the complex can be attrib-
uted to the involvement of metal ions as a candidate for
bacterial growth inhibition, which could be explained by
chelation theory [58].
Gram-positive bacteria have lipopolysaccharides cell
wall. +is wall prevents the accumulation of the complex in
the cell membrane. +erefore, Gram-positive bacteria are
Table 3: Comparison of main peaks in quercetin, quercetin Schiff base, and quercetin Schiff base complex.
Compound V (C�O) V (C�C) V (O-H) V (C-O-C) V (Cu-O)
Quercetin 1707 1554 3296 1277 Absent
Quercetin Schiff base 1695 1558 3308 1282 Absent















Quercetin schiff base complex
Figure 3: FT-IR spectrum of quercetin, quercetin Schiff base, and
quercetin Schiff base complex.
Figure 4: FESEM image of the new nanoscale Cu (II) Schiff base
complex.
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more effective and more sensitive compared to Gram-
negative bacteria.
Transition metal complexes have an important place in
biochemistry [38, 59]. +e antibacterial activity of the
synthesized complex was evaluated and compared with
standard (gentamicin) (Figure 7). +e diameter of the zone
showing complete inhibition is listed (Table 4).
+is study clearly showed that synthesized complex has
reasonable antibacterial activity against both Gram-nega-
tive and positive organisms. Enhanced lipophilic properties
of metal ion sites caused the high antibacterial activity of
the synthesized complex. +e enhanced lipophilicity led to











Figure 6: Possible structure of the complex.
t-BuOOH
t-BuOO Nanoscale Cu (II) complex
Nanoscale Cu (II) complex + t-BuOOH Nanoscale Cu (I) complex + t-BuOO
Nanoscale Cu (I) complex + t-BuOOH + H+ Nanoscale Cu (II) complex + t-BuO + H2O








Scheme 3: Proposed mechanism for the alcohol oxidation by synthesized catalyst.










Figure 5: XRD pattern of the new nanoscale Cu (II) Schiff base complex.
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4. Conclusions
In this study, formation of Schiff base between quercetin and
ethanolamine is investigated.+e reaction was carried out in
ethanolic solution under reflux condition. Quercetin is a
flavonoid with potent antioxidant activity and broad clinical
effect. +e biological activities of quercetin increase when it
is coordinated with metal ions. +is is due to the fact that
after forming the complex, solubility and bioavailability of
quercetin in the body are increased. In the second step, a
novel nanoscale Cu (II) complex was synthesized, and its
catalyst effect in oxidation reactions of alcohols was ex-
amined. Copper is a bioactive metal that plays several roles
in biological processes, such as catalyzing a large number of
biochemical reactions and having a key role in electron
transport in mitochondria. Copper (II) complexes show a
wide variety of biological activities. +ey could be used as
antimicrobial, anti-inflammatory, antitumor, and antiviral
agents. +erefore, Cu(II) complexes are synthesized as a
potential drug. +e spectroscopic data showed the 3-OH
group and imine groups are coordination sites with the
metal ion.
+e alcohol oxidation reaction was performed in green
condition that is in accordance with environmentally
friendly protocols. +e catalyst is highly stable and can be
reused several times without the loss of catalytic activity in
the alcohol oxidation reaction.
Furthermore, the synthesized complex indicated
promising antibacterial activity against E. coli (Gram-neg-
ative) and Staphylococcus aureus (Gram-positive) bacteria.
Staphylococcus aureus has higher antibacterial activity than
E. coli due to the differences between cell structure,
metabolism, and physiology of Gram-positive and Gram-
negative bacteria. +ese factors are influential on the sen-
sitivity of the nanoscaled copper complex on the antibac-
terial activity.
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